Edit

Clever Leaves

https://cleverleaves.com/en/home/

Last activity: 14.02.2022

Active

Categories: ActiveB2BDevelopmentIndustryInformationMedTechProductProductionResearch

Clever Leaves is a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids. Its operations in Colombia and Portugal produce cannabinoid active pharmaceutical ingredients (API) and finished products in flower and extract form to a growing base of B2B customers around the globe. Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale and low-cost production methods, with the world’s most stringent pharmaceutical quality certifications. For more information, please visit https://cleverleaves.com/en/home/

Followers

2.72K

Mentions

Location: United States, New York

Employees: 201-500

Founded date: 2016

Twitter

Youtube

Investors 2

Date	Name	Website
-	One Degree...	onedegreev...
-	Claridge V...	claridgevp...

Mentions in press and media 19

Date	Title	Description
14.02.2022	Clever Leaves Expands Relationship With Cannatrek in Australia With a Two-Year $3.6M Sales Agreement	BOCA RATON, Fla. and MELBOURNE, Australia, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grad...
10.02.2022	Clever Leaves : Announces Preliminary Fourth Quarter and Full Year 2021 Results and Introduces 2022 Outlook - Form 8-K/A	Clever Leaves Announces Preliminary Fourth Quarter and Full Year 2021 Results and Introduces 2022 Outlook Performance Delivers on 2021 Outlook and Provides Solid Foundation for 2022 2022 Outlook and Strategic Growth Objectives Reflect Rampi...
09.02.2022	Clever Leaves : Announces Preliminary Fourth Quarter and Full Year 2021 Results and Introduces 2022 Outlook - Form 8-K	Clever Leaves Announces Preliminary Fourth Quarter and Full Year 2021 Results and Introduces 2022 Outlook Performance Delivers on 2021 Outlook and Provides Solid Foundation for 2022 2022 Outlook and Strategic Growth Objectives Reflect Rampi...
09.02.2022	Clever Leaves Announces Leadership Transition Plan	BOCA RATON, Fla., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today ann...
09.02.2022	Clever Leaves Announces Preliminary Fourth Quarter and Full Year 2021 Results and Introduces 2022 Outlook	Performance Delivers on 2021 Outlook and Provides Solid Foundation for 2022 2022 Outlook and Strategic Growth Objectives Reflect Ramping Commercialization Opportunities Within Core Global Markets BOCA RATON, Fla., Feb. 09, 2022 (GLOBE NEWSW...
03.02.2022	Clever Leaves Appoints George Schultze to Board of Directors	BOCA RATON, Fla., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today app...
26.01.2022	Clever Leaves Enters US Consumer CBD Market	BOCA RATON, Fla., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today ann...
21.12.2021	Clever Leaves' Licensed Expansion Doubles Portuguese Production Capacity and Diversifies Export Potential	BOCA RATON, Fla., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today ann...
21.12.2021	Clever Leaves' Licensed Expansion Doubles Portuguese Production Capacity and Diversifies Export Potential	Clever Leaves’ Expansion in Portugal Has Obtained Licensing from Portugal’s INFARMED BOCA RATON, Fla., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multina...
24.07.2021	Clever Leaves : to Take Advantage of the Approval to Export Medical Cannabis Flower from Colombia	Export of dry cannabis flower from Colombia has been authorized by a new decree that was signed on July 23rd, 2021, at Clever Leaves’ cultivation facility by President Ivan Duque and his ministers. With flower representing an estimated 50% ...
19.07.2021	Clever Leaves : Financing Strengthens the Company's Liquidity Position and Provides Greater Flexibility to Pursue Growth Opportunities (Form 8-K)	Financing Strengthens the Company's Liquidity Position and Provides Greater Flexibility to Pursue Growth Opportunities - Repayment of 2022 Convertible Notes Generates Over $3 Million of Savings NEW YORK, N.Y., July 19, 2021 - Clever Leaves ...
19.07.2021	Clever Leaves : Closes $25 Million Financing from SunStream	– Financing Strengthens the Company’s Liquidity Position and Provides Greater Flexibility to Pursue Growth Opportunities – Repayment of 2022 Convertible Notes Generates Over $3 Million of Savings NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- ...
02.04.2021	Insider Cannabis: New York finally legalizes adult-use marijuana	Employees tend to medical cannabis plants at Pharmocann, an Israeli medical cannabis company in northern Israel. REUTERS/Amir Cohen Welcome to Insider Cannabis, our weekly newsletter where we’re bringing you an inside look at the deals, tre...
02.04.2021	Insider Cannabis: New York finally legalizes adult-use marijuana	Employees tend to medical cannabis plants at Pharmocann, an Israeli medical cannabis company in northern Israel. Amir Cohen/Reuters Redeem now Welcome to Insider Cannabis, our weekly newsletter where we're bringing you an inside look at the...
01.04.2021	CLEVER LEAVES HOLDINGS INC. Clever Leaves : Expands its Presence in Brazil and Peru Through Verdemed Partnership	NEW YORK, April 01, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced an agr...
14.04.2020	Clever Leaves Raises US$14M in Series E Financing	Clever Leaves International Inc., a multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, held the first closing of its Series E financing at US$14m. This brought the company’s total...
14.04.2020	Clever Leaves Nabs $14M Series E	NEW YORK, NY, Clever Leaves today announced the first closing of its Series E financing at $14 million. >> Click here for more funding data on Cleaver Leaves >> To export Cleaver Leaves funding data to PDF and Excel, click h...
-	A new Brazilian clinical trial aims to find out whether medical cannabis can effectively treat the symptoms of “long-haul COVID”	Can medicinal cannabis play a role in the fight against COVID-19? That’s the hypothesis behind a new clinical trial set to begin in January 2022. More specifically, the study — being conducted by InCor, the Heart Institute of the São Paulo ...
-	Special Report - Cannabis in Latin America: "It's Complicated."	Two recent developments in Mexico and Colombia signal forward motion in the growing acceptance of cannabis in Latin America. But while the plant may grow like a weed, the pace of legislative change across the region remains glacial. In June...

Clever Leaves

Investors 2

Mentions in press and media 19

Reviews 0